Dr. Block – The Evolving Cannabis Space
(Summer, 2024)

This June 10, 2024 talk was presented at the request of physicians interested in educational conversations concerning anti-aging medicine. Endocannabinoid science and recent research evaluating the risks vs. benefits of Cannabis has reconsidered its clinical use.

Considering the United States Federal government recently announced that after studying the evidence-based data supporting the use of Marijuana for limited purposes as a medicine, the Drug Enforcement Administration (DEA) has changed it’s disposition on Marijuana as a Schedule 1 Prohibited substance, and now recommends that it be moved into a Schedule 3 Controlled drug status.

Rule-making will be the next stage of a process that ultimately allows physicians to legally prescribe Marijuana for legitimate patient uses. Cannabis’ education, its research, and its interstate commerce are important beneficiaries resulting from this policy change.

Jeffrey S Block, M.D. – Physician-Botanist (Miami, Florida USA).